N-(4-((11.BETA.,16.ALPHA.)-9-FLUORO-11,21-DIHYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-20-OXO-2'H-PREGNA-2,4-DIENO(3,2-C)PYRAZOL-2'-YL)PHENYL)ACETAMIDE
UNII QZ9X9KZ72W
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(4-((11.beta.,16.alpha.)-9-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-20-oxo-2'h-pregna-2,4-dieno(3,2-c)pyrazol-2'-yl)phenyl)acetamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QZ9X9KZ72W.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 54941-94-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C33H40FN3O6 RTFFMERJMLUZNG-NVAKKZHVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(4-((11.beta.,16.alpha.)-9-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-20-oxo-2'h-pregna-2,4-dieno(3,2-c)pyrazol-2'-yl)phenyl)acetamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.